Simple Summary This article discusses the use of peptide receptor radionuclide therapy
(PRRT) as a key treatment method for advanced, unresectable neuroendocrine tumors. It …

Simple Summary Neuroendocrine neoplasms (NENs) are a rare and diverse group of
malignancies which are rising in incidence. Several treatments have been devised for …

Peptide receptor radionuclide therapy (PRRT) has been shown to be an effective treatment
for neuroendocrine tumors (NETs) if curative surgery is not an option. A majority of NETs …

Opinion statement Neuroendocrine tumors (NETs) are a heterogenous group of neoplasms
characterized by varied biological hallmarks and behavior, ranging from indolent to …

In the past decades, the number of neuroendocrine tumours that are detected is increasing.
A relative new and promising therapy for patients with metastasised or inoperable disease is …

Peptide receptor radionuclide therapy (PRRNT) is a molecularly targeted radiation therapy
involving the systemic administration of a radiolabelled peptide designed to target with high …

Abstract Purpose of Review Peptide receptor radionuclide therapy (PRRT) with [177 Lu-
DOTA 0, Tyr 3] octreotate is an effective and safe second-or third-line treatment option for …

The incidence of neuroendocrine tumours (NETs) is increasing, but curative therapeutic
options are limited because diagnosis is often delayed until the tumour has metastasized …

The heterogeneous nature of neuroendocrine tumors, their indolent course and lack of
therapeutic options for the management of advanced cases–together form the Achilles heel …

The concept of using a targeting molecule labeled with a diagnostic radionuclide for using
positron emission tomography or single photon emission computed tomography imaging …